Impact of Baseline Smoking Status and Body Mass Index in Patients With Hidradenitis Suppurativa Treated With Adalimumab or Placebo in Phase 2 or 3 Studies. J of Skin 2017, 1 (3.1), s130. https://doi.org/10.25251/skin.1.supp.129.